Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$553K Buy
14,808
+11,162
+306% +$447K 0.17% 53
2018
Q4
$148K Sell
3,646
-426
-10% -$17.7K 0.05% 76
2018
Q3
$170K Buy
4,072
+760
+23% +$29.3K 0.05% 70
2018
Q2
$117K Buy
3,312
+292
+10% +$9.98K 0.04% 85
2018
Q1
$105K Sell
3,020
-732
-20% -$25.2K 0.04% 83
2017
Q4
$131K Buy
3,752
+3
+0.1% +$102 0.04% 79
2017
Q3
$127K Sell
3,749
-80
-2% -$2.57K 0.05% 76
2017
Q2
$120K Sell
3,829
-591
-13% -$18.6K 0.04% 74
2017
Q1
$143K Buy
4,420
+4
+0.1% +$126 0.06% 73
2016
Q4
$136K Sell
4,416
-260
-6% -$7.94K 0.06% 73
2016
Q3
$150K Buy
+4,676
New +$156K 0.06% 65
2015
Q4
Sell
-4,862
Closed -$145K 215
2015
Q3
$145K Buy
+4,862
New +$156K 0.07% 75

Other funds holding PFE

Live Your Vision's PFE Position: Q1 2019 in Review

Live Your Vision increased its Pfizer (PFE) stake by 306% in Q1 2019, buying an estimated $447K and bringing the position to 14,808 shares worth $553K. The position accounts for 0.17% of the portfolio, ranked #53.

Live Your Vision first reported a position in PFE in Q3 2015 and has held it in 12 quarters since. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • Live Your Vision held 14,808 shares of Pfizer worth $553K as of Q1 2019.
  • Live Your Vision bought 11,162 Pfizer shares in Q1 2019, an estimated $447K.
  • Pfizer made up 0.17% of Live Your Vision's portfolio in Q1 2019, its #53 holding.
  • Live Your Vision first reported a position in Pfizer in Q3 2015 and has held it in 12 quarters since.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Live Your Vision's 13F filing for Q1 2019, filed 25 Apr 2019.